SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001659617-18-000059
Filing Date
2018-05-15
Accepted
2018-05-15 08:30:25
Documents
2
Period of Report
2018-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k33118earningsrelease.htm 8-K 15405
2 EXHIBIT 99.1 exh991-financials33118q120.htm EX-99.1 106700
  Complete submission text file 0001659617-18-000059.txt   123235
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 18833222
SIC: 2834 Pharmaceutical Preparations